Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, March 3, 2017 at 11:00 am local time (EET)

 

Person subject to the notification requirement
Name: Korpela, Semi  
Position: Chief Executive Officer
     
Initial Notification  
Reference number: 74370089ATTSNBXJVT29_20170302113238_1
     
Issuer
Name: Biohit Oyj
LEI: 74370089ATTSNBXJVT29
     
Transaction details
Transaction date: 2017-03-01
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Acquisition
 
Instrument: Share
ISIN: FI0009005482
 
Volume: 1240
Unit price: 5,29000 Euro
 
Aggregated transactions
Volume: 1240
Volume weighted average price: 5.29000 Euro

 

Additional information: 

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861

investor.relations@biohit.fi
www.biohithealthcare.com


Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

Subscribe